[go: up one dir, main page]

PL2776048T3 - Kompozycje farmaceutyczne zawierające pediococcus i sposoby łagodzenia objawów zespołów gastroenterologicznych - Google Patents

Kompozycje farmaceutyczne zawierające pediococcus i sposoby łagodzenia objawów zespołów gastroenterologicznych

Info

Publication number
PL2776048T3
PL2776048T3 PL12796855T PL12796855T PL2776048T3 PL 2776048 T3 PL2776048 T3 PL 2776048T3 PL 12796855 T PL12796855 T PL 12796855T PL 12796855 T PL12796855 T PL 12796855T PL 2776048 T3 PL2776048 T3 PL 2776048T3
Authority
PL
Poland
Prior art keywords
gastroenterological
syndromes
symptoms
reducing
methods
Prior art date
Application number
PL12796855T
Other languages
English (en)
Inventor
Stephen F. Olmstead
Original Assignee
Prothera, Inc.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Prothera, Inc. filed Critical Prothera, Inc.
Publication of PL2776048T3 publication Critical patent/PL2776048T3/pl

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66—Microorganisms or materials therefrom
    • A61K35/74—Bacteria
    • A61K35/741—Probiotics
    • A61K35/744—Lactic acid bacteria, e.g. enterococci, pediococci, lactococci, streptococci or leuconostocs
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/135—Bacteria or derivatives thereof, e.g. probiotics
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/20—Reducing nutritive value; Dietetic products with reduced nutritive value
    • A23L33/21—Addition of substantially indigestible substances, e.g. dietary fibres
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66—Microorganisms or materials therefrom
    • A61K35/74—Bacteria
    • A61K35/741—Probiotics
    • A61K35/744—Lactic acid bacteria, e.g. enterococci, pediococci, lactococci, streptococci or leuconostocs
    • A61K35/745—Bifidobacteria
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66—Microorganisms or materials therefrom
    • A61K35/74—Bacteria
    • A61K35/741—Probiotics
    • A61K35/744—Lactic acid bacteria, e.g. enterococci, pediococci, lactococci, streptococci or leuconostocs
    • A61K35/747—Lactobacilli, e.g. L. acidophilus or L. brevis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/14—Prodigestives, e.g. acids, enzymes, appetite stimulants, antidyspeptics, tonics, antiflatulents
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2200/00—Function of food ingredients
    • A23V2200/30—Foods, ingredients or supplements having a functional effect on health
    • A23V2200/32—Foods, ingredients or supplements having a functional effect on health having an effect on the health of the digestive tract
    • A23V2200/3204—Probiotics, living bacteria to be ingested for action in the digestive tract
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2400/00—Lactic or propionic acid bacteria
    • A23V2400/41—Pediococcus
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Mycology (AREA)
  • Chemical & Material Sciences (AREA)
  • Microbiology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Nutrition Science (AREA)
  • Food Science & Technology (AREA)
  • Polymers & Plastics (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Quinoline Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Saccharide Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
PL12796855T 2011-06-10 2012-06-08 Kompozycje farmaceutyczne zawierające pediococcus i sposoby łagodzenia objawów zespołów gastroenterologicznych PL2776048T3 (pl)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US13/067,582 US9579353B2 (en) 2011-06-10 2011-06-10 Pharmaceutical compositions containing pediococcus and methods for reducing the symptoms of gastroenterological syndromes
EP12796855.0A EP2776048B1 (en) 2011-06-10 2012-06-08 Pharmaceutical compositions containing pediococcus and methods for reducing the symptoms of gastroenterological syndromes
PCT/US2012/041697 WO2012170915A1 (en) 2011-06-10 2012-06-08 Pharmaceutical compositions containing pediococcus and methods for reducing the symptoms of gastroenterological syndromes

Publications (1)

Publication Number Publication Date
PL2776048T3 true PL2776048T3 (pl) 2020-05-18

Family

ID=47293372

Family Applications (1)

Application Number Title Priority Date Filing Date
PL12796855T PL2776048T3 (pl) 2011-06-10 2012-06-08 Kompozycje farmaceutyczne zawierające pediococcus i sposoby łagodzenia objawów zespołów gastroenterologicznych

Country Status (12)

Country Link
US (1) US9579353B2 (pl)
EP (2) EP3598979A1 (pl)
JP (2) JP6046129B2 (pl)
KR (2) KR101925508B1 (pl)
CN (1) CN103764154A (pl)
AU (1) AU2012267516B2 (pl)
CA (1) CA2837479C (pl)
DK (1) DK2776048T3 (pl)
ES (1) ES2761333T3 (pl)
PL (1) PL2776048T3 (pl)
PT (1) PT2776048T (pl)
WO (1) WO2012170915A1 (pl)

Families Citing this family (88)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR20150118084A (ko) * 2012-09-20 2015-10-21 프로테라 인코포레이티드 비만 및 비만 관련 질환을 치료하기 위한 프로바이오틱 조성물 및 방법
US8906668B2 (en) 2012-11-23 2014-12-09 Seres Health, Inc. Synergistic bacterial compositions and methods of production and use thereof
CN104955466A (zh) 2012-11-23 2015-09-30 赛里斯治疗公司 协同细菌组合物和其制造方法和用途
US20150246082A1 (en) * 2013-01-08 2015-09-03 Imagilin Technology, Llc Pediococcus-Based Probiotics for Body Weight Control
WO2014121304A1 (en) * 2013-02-04 2014-08-07 Seres Health, Inc. Compositions and methods
KR102222273B1 (ko) 2013-02-04 2021-03-08 세레스 테라퓨틱스, 인코포레이티드 조성물 및 방법
RU2519766C1 (ru) * 2013-03-05 2014-06-20 Зухра Фаниловна Эделева Способ лечения гастрита
MX2013002737A (es) * 2013-03-11 2014-09-22 Siegfried Rhein S A De C V Combinaciones con probioticos para restablecer alteraciones de la funcion intestinal.
WO2014145958A2 (en) 2013-03-15 2014-09-18 Seres Health, Inc. Network-based microbial compositions and methods
US10130664B2 (en) 2013-05-10 2018-11-20 BiOWiSH Technologies, Inc. Compositions and methods for decreasing the effects of alcohol
WO2015018883A2 (en) 2013-08-09 2015-02-12 Ab-Biotics, S.A. Probiotic for infantile excessive crying
WO2015021936A1 (en) * 2013-08-16 2015-02-19 The University Of Hong Kong Method and compositions for treating cancer using probiotics cross-reference to related application
WO2015047941A2 (en) * 2013-09-27 2015-04-02 Trachtman Ira Milton Compositions and methods for treatment and prophylaxis of gastrointestinal diseases
EP3074027B1 (en) 2013-11-25 2024-12-18 Seres Therapeutics, Inc. Synergistic bacterial compositions and methods of production and use thereof
EP3082431A4 (en) 2013-12-16 2017-11-15 Seres Therapeutics, Inc. Bacterial compositions and methods of use thereof for treatment of immune system disorders
CA2947436A1 (en) * 2014-05-12 2015-11-19 BiOWiSH Technologies, Inc. Compositions and methods for improving human health and nutrition
KR101635997B1 (ko) * 2014-07-11 2016-07-07 한국식품연구원 페디오코쿠스 에시디락티시(Pediococcus acidilactici)를 유효성분으로 포함하는 Ｔｈ1-매개 면역 질환 또는 Ｔｈ2-매개 면역 질환의 예방, 개선 또는 치료용 조성물
AU2015296538B2 (en) * 2014-07-29 2019-01-31 BiOWiSH Technologies, Inc. Animal feed compositions and feed additives
MX382478B (es) 2014-10-24 2025-03-13 Infinant Health Inc Bifidobacterias activadas y metodos de uso de las mismas.
US20160128337A1 (en) * 2014-11-07 2016-05-12 BiOWiSH Technologies, Inc. Antibacterial compositions and methods of use
CN116270760A (zh) * 2015-03-13 2023-06-23 英凡特健康有限公司 代谢或隔绝游离的糖单体的组合物及其应用
CN107530381A (zh) * 2015-04-23 2018-01-02 达能日尔维公司 用于减少肠道气体产生的组合物
WO2016205394A1 (en) * 2015-06-15 2016-12-22 Amnat Global Llc Multistrain probiotic blends for treatment of gastrointestinal conditions and improving or maintaining gastrointestinal health
KR101890428B1 (ko) * 2015-08-13 2018-10-01 한국식품연구원 페디오코쿠스 펜토사세우스(Pediococcus pentosaceus)를 유효성분으로 포함하는 Th1-매개 면역 질환, Th17-매개 면역 질환 또는 Th2-매개 면역 질환의 예방, 개선 또는 치료용 조성물
CN108135948B (zh) * 2015-08-25 2022-04-12 免疫生物技术医疗瑞典公司 用于治疗和预防肠感染和炎症的组合物和方法
CN107206033B (zh) * 2016-01-07 2021-04-27 萨米莱布斯有限公司 使用凝结芽孢杆菌sbc37-01，mtcc 5856治疗性处理腹泻型肠易激综合征的方法
WO2018073963A1 (ja) * 2016-10-21 2018-04-26 森永乳業株式会社 気分プロフィール改善剤
CN106666738A (zh) * 2016-12-13 2017-05-17 合肥赛为智慧医疗有限公司 一种用于改善人体代谢紊乱状态的组合物及其制备方法
EP3554284A4 (en) * 2016-12-18 2020-08-26 University of Florida Research Foundation, Inc. LACTOBACILLUS SUPPLEMENT TO PROMOTE GASTRIC AND IMMUNE HEALTH
US11304985B2 (en) 2017-03-10 2022-04-19 Biohm Health Llc Compositions and methods for promoting a healthy microbial flora in a mammal
WO2018218159A1 (en) * 2017-05-26 2018-11-29 Crestovo Holdings Llc Lyophilized compositions comprising fecal microbe-based therapeutic agents and methods for making and using same
AU2018282018B2 (en) * 2017-06-09 2021-11-04 Sami Labs Limited Compositions and methods for reducing flatulence
RS63393B1 (sr) 2017-06-14 2022-08-31 4D Pharma Res Ltd Kompozicije koje sadrže bakterijske sojeve
CN107929329B (zh) * 2017-07-07 2023-06-06 西北民族大学 一种消栓降脂益生复合菌中药颗粒及其制备方法
IT201700080515A1 (it) * 2017-07-17 2017-10-17 Gianfranco Caramelli Integratore di microorganismi microincapsulati associati con prebiotici e vitamine che permette di riportare in equilibrio tutta la flora intestinale
BR112020002992A2 (pt) 2017-08-14 2020-08-18 Seres Therapeutics, Inc. composições e métodos para tratamento de doença colestática
CA3077235A1 (en) * 2017-09-28 2019-04-04 Commonwealth Scientific And Industrial Research Organisation Isothiocyanate containing brassicaceae products and method of preparation thereof
CA3080586A1 (en) 2017-10-30 2019-05-09 Seres Therapeutics, Inc. Compositions and methods for treating antibiotic resistance
WO2019093611A1 (ko) * 2017-11-10 2019-05-16 (주)앰틱스바이오 신규한 페디오코커스 펜토사세우스 에이비160011 균주 및 이를 포함하는 조성물
KR102052047B1 (ko) 2017-12-13 2019-12-04 대한민국(환경부 국립생물자원관장) 항균 활성을 나타내는 페디오코커스 펜토사세우스 균주 및 이의 용도
KR101915951B1 (ko) 2018-01-09 2018-11-07 주식회사 쎌바이오텍 P8 단백질을 발현 및 분비하는 위장관 질환 치료 약물 전달용 미생물 및 그를 포함하는 위장관 질환 예방 또는 치료용 약제학적 조성물
CN108464985B (zh) * 2018-03-05 2020-05-12 复旦大学附属中山医院 用于建立比格犬心功能不全模型的方法和试剂盒
CA3092548A1 (en) * 2018-03-05 2019-09-12 Bio-K Plus International Inc. Combination of lactobacilli for the relief of irritable bowel syndrome and for the relief of other gastrointestinal disorders
BR112020018360A2 (pt) * 2018-03-09 2020-12-29 Biohm Health Llc Composições para uso no equilíbrio do microbioma
WO2019195592A1 (en) * 2018-04-04 2019-10-10 The University Of Chicago Genetically-engineered microbes and compositions thereof
RU2675110C1 (ru) * 2018-04-09 2018-12-17 Федеральное государственное бюджетное учреждение науки Институт общей генетики им. Н.И. Вавилова Российской академии наук (ИОГЕН РАН) Фармацевтическая композиция для терапии воспалительных заболеваний слизистых оболочек кишечника на основе штамма Lactobacillus brevis 47f, проявляющая местную противовоспалительную активность
US11957721B2 (en) * 2018-04-11 2024-04-16 Yissum Research Development Company Of The Hebrew University Of Jerusalem Ltd. Edible plant parts enriched with probiotic bacteria
WO2019211341A1 (en) * 2018-05-01 2019-11-07 Chr. Hansen A/S Probiotic bifidobacterium breve strain and compositions comprising said strain
JP7088573B2 (ja) * 2018-05-23 2022-06-21 コバイオラブズ・インコーポレイテッド ラクトバチルス・ガッセリーｋｂｌ６９７株及びその使用
CN108949613B (zh) * 2018-06-13 2021-03-23 湖北华大瑞尔科技有限公司 一种辅助抗生素的益生菌制剂及其制备方法
KR102223657B1 (ko) 2018-09-04 2021-03-08 주식회사 제노포커스 염증성 장질환 예방 또는 치료용 약학적 조성물
KR102251294B1 (ko) * 2018-11-06 2021-05-12 주식회사 메디뉴트롤 락토바실러스 살리바리우스 v133 균주의 사균체를 유효성분으로 함유하는 알코올성 위염의 예방, 개선 또는 치료용 조성물
KR102434641B1 (ko) * 2018-11-23 2022-08-23 한국식품연구원 페디오코쿠스 펜토사세우스를 이용한 호흡기 기능 개선용 식품 조성물
CN109652334A (zh) * 2019-01-11 2019-04-19 谭瑛 一种微生物复合菌剂及其制备方法和应用
KR102158667B1 (ko) * 2019-05-09 2020-09-22 한국 한의학 연구원 면역기능 조절 및 염증성 장질환의 개선효과를 갖는 페디오코쿠스 이노피나투스 WiKim0108 균주 및 이의 용도
CN110179121A (zh) * 2019-05-13 2019-08-30 湖南唯乐可健康产业有限公司 一种改善肠道的五联益生菌组合物、复合固体饮料及其制备方法和应用
US20220160794A1 (en) * 2019-05-14 2022-05-26 Ormendes Sa Use of bacillus amyloliquefaciens and/or bacillus subtilis for the enhancement of active probiotic compositions or for the activation of inactive probiotic compositions, compositions thus obtained, and related method
CN110079485B (zh) * 2019-05-31 2020-09-25 江南大学 缓解抑郁的乳酸片球菌ccfm6432、其发酵食品及其应用
JP6739602B1 (ja) * 2019-07-24 2020-08-12 雪印メグミルク株式会社 記憶・学習能維持および／または向上用組成物及び組成物を含む食品、医薬品、飼料
IT201900014388A1 (it) * 2019-08-08 2021-02-08 Univ Cattolica Del Sacro Cuore Consorzio di probiotici
WO2021055492A1 (en) * 2019-09-16 2021-03-25 Microbiome Labs, Llc Spore-based probiotic supplementation in dogs and control of endotoxemia
JP2023507383A (ja) * 2019-12-17 2023-02-22 メタジェニックス，インコーポレイティド 多系統プロバイオティクス組成物およびその使用
KR102500854B1 (ko) * 2019-12-17 2023-02-17 한국 한의학 연구원 페디오코쿠스 이노피나투스를 유효성분으로 포함하는 숙취해소용 조성물
CN115551990B (zh) * 2020-02-26 2024-09-20 Gi生物群系公司 瑞士乳杆菌菌株及含有其的用于预防或治疗炎性疾病的组合物
CN111150067A (zh) * 2020-03-24 2020-05-15 西安交通大学医学院第一附属医院 一种保护胃黏膜的组合物和保健食品
CN111671090A (zh) * 2020-05-26 2020-09-18 颜如玉医药科技有限公司 一种益生菌组合物及其制剂
TWI739495B (zh) * 2020-06-29 2021-09-11 豐華生物科技股份有限公司 可促進排便的組合物及其用途
US20230398160A1 (en) * 2020-10-30 2023-12-14 National University Of Singapore Probiotic compositions and methods against intestinal barrier dysfunction and heat stress
WO2022103321A2 (en) * 2020-11-12 2022-05-19 Synbiotics Ab Synbiotic composition
JP2024506463A (ja) * 2021-01-05 2024-02-14 ラクトバイオ アー／エス 菌株、組成物および使用方法
CN113018320A (zh) * 2021-02-04 2021-06-25 四川农业大学 约氏乳杆菌bs15在制备预防和/或治疗慢性氟中毒导致的肠道损伤药物中的应用
IT202100007682A1 (it) * 2021-03-29 2022-09-29 Synbalance Srl Composizioni probiotiche utili nella prevenzione e/o nel trattamento di disturbi gastrointestinali
CN115919907A (zh) * 2021-08-31 2023-04-07 E·施约林 一种用于治疗和/或预防食物和/或酒精中毒的组合物
KR102390775B1 (ko) * 2021-09-06 2022-05-04 한국식품연구원 류코노스톡 슈도메센테로이데스 WiKim0138 균주를 유효성분으로 포함하는 암의 예방 또는 치료용 조성물
CN114196599A (zh) * 2022-01-06 2022-03-18 北京浩鼎瑞微生态科技研究院有限公司 一种用于肠道菌群调和的微生物组合物及其制备方法
CN114504623A (zh) * 2022-04-19 2022-05-17 广东益可维生物技术有限公司 改善气虚型便秘的中药益生菌复合制品及其制备方法
CN115747111B (zh) * 2022-11-25 2023-12-12 四川大学 一株戊糖片球菌及其应用
CN116262125B (zh) * 2023-01-19 2023-11-14 哈尔滨美华生物技术股份有限公司 保护胃黏膜、缓解胃炎的干酪乳杆菌l7-13及其应用
CN116179443A (zh) * 2023-03-13 2023-05-30 青岛诺森生物技术有限责任公司 一株缓解便秘的乳酸片球菌nss0302及其应用
CN116121154B (zh) * 2023-04-10 2023-06-27 四川厌氧生物科技有限责任公司 一种乳明串珠菌及其应用
EP4501339A1 (en) * 2023-07-31 2025-02-05 Igen Biolab Group AG Postbiotic composition for skin disorders and cosmetic use
TWI857740B (zh) * 2023-08-09 2024-10-01 統一企業股份有限公司 複合益生菌粉及其用途以及益生菌組合物
CN116831258A (zh) * 2023-08-10 2023-10-03 广州金叶健康科技有限公司 一种调节口腔菌群的益生菌饮料及其制备方法
US20250295710A1 (en) * 2023-11-21 2025-09-25 Kedar Prasad Prebiotic and probiotic formulation containing acid and heat resistant bacteria
CN117736943B (zh) * 2024-02-20 2024-05-24 山东中科嘉亿生物工程有限公司 一种改善肠易激综合征的复合菌剂及其制备方法和用途
EP4609871A1 (en) * 2024-02-28 2025-09-03 Pronaos s.r.o. Probiotic composition for treating ibs
WO2025229094A1 (en) * 2024-04-30 2025-11-06 N.V. Nutricia Mixture of non-digestible saccharides stimulates gut barier
WO2025229097A1 (en) * 2024-04-30 2025-11-06 N.V. Nutricia Synbiotic mixture for young children

Family Cites Families (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6241983B1 (en) 1994-10-28 2001-06-05 Metagenics, Inc. Bacteria-and fiber-containing composition for human gastrointestinal health
US6447772B1 (en) 1999-10-01 2002-09-10 Klaire Laboratories, Inc. Compositions and methods relating to reduction of symptoms of autism
US6251391B1 (en) 1999-10-01 2001-06-26 Klaire Laboratories, Inc. Compositions containing dipepitidyl peptidase IV and tyrosinase or phenylalaninase for reducing opioid-related symptons
ITMI20020399A1 (it) * 2002-02-28 2003-08-28 Ct Sperimentale Del Latte S P Composizioni dietetiche e/o farmaceutiche per uso umano e/o animale abase di preparati microbici probiotici
EP1384483A1 (en) * 2002-07-23 2004-01-28 Nestec S.A. Probiotics for treatment of irritable bowel disease (IBS) through improvement of gut neuromuscular function
US20040247580A1 (en) 2003-06-06 2004-12-09 Myung-Jun Chung Process for preparing double-coated lactic acid bacteria powder using protein and polysaccharide and product by the same
WO2004110466A2 (en) 2003-06-13 2004-12-23 N.V. Nutricia Pediocin-producing pediococci
US8871266B2 (en) 2003-10-01 2014-10-28 Commonwealth Scientific & Industrial Research Organisation Probiotic storage and delivery
SE0400355D0 (sv) * 2004-02-17 2004-02-17 Synbiotics Ab New synbiotec use
US20050186188A1 (en) * 2004-02-19 2005-08-25 Peilin Guo Compositions containing probiotics and polysaccharides and methods of use
US20060008511A1 (en) * 2004-07-08 2006-01-12 Jhy-Jhu Lin Probiotic products for pet applications
US7935334B2 (en) 2005-07-07 2011-05-03 Imagilin Technologies, LLC Probiotics as alternative medicines against infectious diseases
JP5363811B2 (ja) * 2005-09-28 2013-12-11 ノルディスク リバランス アクティーゼルスカブ 治療エフェクターとしてプロバイオティック細菌と発酵穀物を用いるｉｂｄ及びｉｂｓの治療
US20100330151A1 (en) * 2009-06-25 2010-12-30 Mary Elaine Freeland Method of Promoting Gastrointestinal Health Using a Combination of a Probiotic Microorganism and Chocolate
US9364507B2 (en) * 2009-08-11 2016-06-14 Imagilin Technology, Llc Probiotic enhancement of steroid and immune suppressor activity in mammals with chronic diseases
JP2013507394A (ja) * 2009-10-09 2013-03-04 プロセラ インコーポレイテッド 自閉症スペクトル障害と診断されたヒトにおいて自閉症スペクトル障害に関連する少なくとも一つの症状を低減するための、ペディオコッカス属を含む組成物及び方法
WO2011092261A1 (en) * 2010-01-28 2011-08-04 Ab-Biotics S.A. Probiotic composition for use in the treatment of bowel inflammation

Also Published As

Publication number Publication date
ES2761333T3 (es) 2020-05-19
CA2837479A1 (en) 2012-12-13
CA2837479C (en) 2021-06-22
KR101925508B1 (ko) 2018-12-05
AU2012267516B2 (en) 2017-08-10
JP6444358B2 (ja) 2018-12-26
KR102032474B1 (ko) 2019-10-15
JP6046129B2 (ja) 2016-12-14
KR20180131638A (ko) 2018-12-10
EP2776048A4 (en) 2015-08-19
AU2012267516A1 (en) 2014-01-23
EP3598979A1 (en) 2020-01-29
CN103764154A (zh) 2014-04-30
KR20140053950A (ko) 2014-05-08
US20120315249A1 (en) 2012-12-13
US9579353B2 (en) 2017-02-28
JP2014520114A (ja) 2014-08-21
JP2017036335A (ja) 2017-02-16
WO2012170915A1 (en) 2012-12-13
EP2776048B1 (en) 2019-09-18
DK2776048T3 (da) 2019-12-16
PT2776048T (pt) 2020-01-06
EP2776048A1 (en) 2014-09-17

Similar Documents

Publication Publication Date Title
EP2776048A4 (en) PHARMACEUTICAL COMPOSITIONS WITH PEDIOCOCCUS AND METHOD FOR REDUCING THE SYMPTOMS OF GASTROENTEROLOGICAL SYNDROME
IL276012A (en) Pharmaceutical preparations containing sorbitan esters
IL230010B (en) Inhalable pharmaceutical ingredients
GB201113662D0 (en) Pharmaceutical compositions
AP3656A (en) Pharmaceutical compositions
ZA201308208B (en) Pharmaceutical compositions
IL230528A0 (en) An abuse-resistant pharmaceutical preparation for the treatment of opioid addiction
HUE036400T2 (hu) Omeprazol gyógyszerkészítmény
HRP20141240T1 (en) An inhalable pharmaceutical composition
SG10201604468QA (en) Shk-based pharmaceutical compositions and methods of manufacturing and using the same
PT3081097T (pt) Composição para o tratamento da infertilidade
GB201118181D0 (en) Pharmaceutical compositions
PH12014501052A1 (en) Methods and compositions for the treatment of diabetes and related symptoms
ZA201502849B (en) Methods for alleviating symptoms of multiple sclerosis based on apoaequorin-containing compositions
EP2730283A4 (en) PHARMACEUTICAL COMPOSITION FOR INFLAMMATORY DISEASES, ALLERGIC DISEASES AND AUTOIMMUNE DISEASES